Global Std Self Diagnostics Market

Std Self Diagnostics Comprehensive Study by Type (Testing Kit, Testing Device, Testing Strip/chip), Application (Hospitals, Homecare, Diagnostic Centres, Others), Usability (Reusable, Disposable), Testing (Chlamydia Testing, Gonorrhoea Testing, Hepatitis C Testing, HIV Testing, Syphilis Testing, Trichomonas’s Testing) Players and Region - Global Market Outlook to 2027

Std Self Diagnostics Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Std Self Diagnostics
Sexually Transmitted disease (STD) is caused by a bacterial or viral infection within the body. More than thirty different infections are transmitted through the exchange of semen, blood, and alternative body fluids; or by direct contact with the affected body areas of individuals with stds. The rising prevalence of sexually transmitted diseases is a major driver for this market. Besides this, each developed and developing countries elevated their healthcare expenditure and spent on new technologies and research and Development to extend the health quality of the population.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


A Modern culture of developing region also add up in more cases of STIs patients. Also, the advancement in technologies adds up. These factors enhance the STD self-diagnostics sales during the forecast period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Danaher Corporation (United States), Affymetrix (United States), BioMerieux (France), Cepheid Inc. (United States), Bio-Rad Laboratories (United States), Alere Inc. (United States), DiaSorin (Italy), Orasure (United States), F. Hoffmann-La Roche (Switzerland), Abbott Laboratories (United States) and Becton Dickinson and Company (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Std Self Diagnostics market by Type (Testing Kit, Testing Device and Testing Strip/chip), Application (Hospitals, Homecare, Diagnostic Centres and Others) and Region.



On the basis of geography, the market of Std Self Diagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Usability, the sub-segment i.e. Reusable will boost the Std Self Diagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Testing, the sub-segment i.e. Chlamydia Testing will boost the Std Self Diagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
In 2020, Stratos Genomics was acquired by F. Hoffmann-La Roche Ltd. This improves the diagnostics division of the company.
In January 2020, Central Disease control continued support speciality clinics by scaling up HIV prevention services in STD with the help of Notice of Funding Opportunity (NOFO).


Market Drivers
  • Increasing Prevalence of Sexually Transmitted Diseases
  • Increasing Cases in The Developing Regions

Opportunities
  • Research And Development Activities
  • Advancement And Adoption of New Technologies

Restraints
  • High Cost of The Kit

Challenges
  • Lack Of Awareness About the Diagnosis


Key Target Audience
Manufacturers of Std Self Diagnostics, Suppliers and distributors of Std Self Diagnostics, Vendors of Std Self Diagnostics, Raw Material Supplier of Std Self Diagnostics, Governmental and Regulatory bodies and End-Users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Testing Kit
  • Testing Device
  • Testing Strip/chip
By Application
  • Hospitals
  • Homecare
  • Diagnostic Centres
  • Others
By Usability
  • Reusable
  • Disposable

By Testing
  • Chlamydia Testing
  • Gonorrhoea Testing
  • Hepatitis C Testing
  • HIV Testing
  • Syphilis Testing
  • Trichomonas’s Testing

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Sexually Transmitted Diseases
      • 3.2.2. Increasing Cases in The Developing Regions
    • 3.3. Market Challenges
      • 3.3.1. Lack Of Awareness About the Diagnosis
    • 3.4. Market Trends
      • 3.4.1. Increase In Recommendation from Doctor
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Std Self Diagnostics, by Type, Application, Usability, Testing and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Std Self Diagnostics (Value)
      • 5.2.1. Global Std Self Diagnostics by: Type (Value)
        • 5.2.1.1. Testing Kit
        • 5.2.1.2. Testing Device
        • 5.2.1.3. Testing Strip/chip
      • 5.2.2. Global Std Self Diagnostics by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Homecare
        • 5.2.2.3. Diagnostic Centres
        • 5.2.2.4. Others
      • 5.2.3. Global Std Self Diagnostics by: Usability (Value)
        • 5.2.3.1. Reusable
        • 5.2.3.2. Disposable
      • 5.2.4. Global Std Self Diagnostics by: Testing (Value)
        • 5.2.4.1. Chlamydia Testing
        • 5.2.4.2. Gonorrhoea Testing
        • 5.2.4.3. Hepatitis C Testing
        • 5.2.4.4. HIV Testing
        • 5.2.4.5. Syphilis Testing
        • 5.2.4.6. Trichomonas’s Testing
      • 5.2.5. Global Std Self Diagnostics Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Std Self Diagnostics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Danaher Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Affymetrix (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BioMerieux (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cepheid Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bio-Rad Laboratories (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Alere Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. DiaSorin (Italy)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Orasure (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. F. Hoffmann-La Roche (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Abbott Laboratories (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Becton Dickinson and Company (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Std Self Diagnostics Sale, by Type, Application, Usability, Testing and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Std Self Diagnostics (Value)
      • 7.2.1. Global Std Self Diagnostics by: Type (Value)
        • 7.2.1.1. Testing Kit
        • 7.2.1.2. Testing Device
        • 7.2.1.3. Testing Strip/chip
      • 7.2.2. Global Std Self Diagnostics by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Homecare
        • 7.2.2.3. Diagnostic Centres
        • 7.2.2.4. Others
      • 7.2.3. Global Std Self Diagnostics by: Usability (Value)
        • 7.2.3.1. Reusable
        • 7.2.3.2. Disposable
      • 7.2.4. Global Std Self Diagnostics by: Testing (Value)
        • 7.2.4.1. Chlamydia Testing
        • 7.2.4.2. Gonorrhoea Testing
        • 7.2.4.3. Hepatitis C Testing
        • 7.2.4.4. HIV Testing
        • 7.2.4.5. Syphilis Testing
        • 7.2.4.6. Trichomonas’s Testing
      • 7.2.5. Global Std Self Diagnostics Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Std Self Diagnostics: by Type(USD Million)
  • Table 2. Std Self Diagnostics Testing Kit , by Region USD Million (2016-2021)
  • Table 3. Std Self Diagnostics Testing Device , by Region USD Million (2016-2021)
  • Table 4. Std Self Diagnostics Testing Strip/chip , by Region USD Million (2016-2021)
  • Table 5. Std Self Diagnostics: by Application(USD Million)
  • Table 6. Std Self Diagnostics Hospitals , by Region USD Million (2016-2021)
  • Table 7. Std Self Diagnostics Homecare , by Region USD Million (2016-2021)
  • Table 8. Std Self Diagnostics Diagnostic Centres , by Region USD Million (2016-2021)
  • Table 9. Std Self Diagnostics Others , by Region USD Million (2016-2021)
  • Table 10. Std Self Diagnostics: by Usability(USD Million)
  • Table 11. Std Self Diagnostics Reusable , by Region USD Million (2016-2021)
  • Table 12. Std Self Diagnostics Disposable , by Region USD Million (2016-2021)
  • Table 13. Std Self Diagnostics: by Testing(USD Million)
  • Table 14. Std Self Diagnostics Chlamydia Testing , by Region USD Million (2016-2021)
  • Table 15. Std Self Diagnostics Gonorrhoea Testing , by Region USD Million (2016-2021)
  • Table 16. Std Self Diagnostics Hepatitis C Testing , by Region USD Million (2016-2021)
  • Table 17. Std Self Diagnostics HIV Testing , by Region USD Million (2016-2021)
  • Table 18. Std Self Diagnostics Syphilis Testing , by Region USD Million (2016-2021)
  • Table 19. Std Self Diagnostics Trichomonas’s Testing , by Region USD Million (2016-2021)
  • Table 20. South America Std Self Diagnostics, by Country USD Million (2016-2021)
  • Table 21. South America Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 22. South America Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 23. South America Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 24. South America Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 25. Brazil Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 26. Brazil Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 27. Brazil Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 28. Brazil Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 29. Argentina Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 30. Argentina Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 31. Argentina Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 32. Argentina Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 33. Rest of South America Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 34. Rest of South America Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 35. Rest of South America Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 36. Rest of South America Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 37. Asia Pacific Std Self Diagnostics, by Country USD Million (2016-2021)
  • Table 38. Asia Pacific Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 39. Asia Pacific Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 40. Asia Pacific Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 41. Asia Pacific Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 42. China Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 43. China Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 44. China Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 45. China Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 46. Japan Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 47. Japan Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 48. Japan Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 49. Japan Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 50. India Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 51. India Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 52. India Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 53. India Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 54. South Korea Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 55. South Korea Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 56. South Korea Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 57. South Korea Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 58. Taiwan Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 59. Taiwan Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 60. Taiwan Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 61. Taiwan Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 62. Australia Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 63. Australia Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 64. Australia Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 65. Australia Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 66. Rest of Asia-Pacific Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 67. Rest of Asia-Pacific Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 68. Rest of Asia-Pacific Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 69. Rest of Asia-Pacific Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 70. Europe Std Self Diagnostics, by Country USD Million (2016-2021)
  • Table 71. Europe Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 72. Europe Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 73. Europe Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 74. Europe Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 75. Germany Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 76. Germany Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 77. Germany Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 78. Germany Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 79. France Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 80. France Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 81. France Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 82. France Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 83. Italy Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 84. Italy Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 85. Italy Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 86. Italy Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 87. United Kingdom Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 88. United Kingdom Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 89. United Kingdom Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 90. United Kingdom Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 91. Netherlands Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 92. Netherlands Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 93. Netherlands Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 94. Netherlands Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 95. Rest of Europe Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 96. Rest of Europe Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 97. Rest of Europe Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 98. Rest of Europe Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 99. MEA Std Self Diagnostics, by Country USD Million (2016-2021)
  • Table 100. MEA Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 101. MEA Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 102. MEA Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 103. MEA Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 104. Middle East Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 105. Middle East Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 106. Middle East Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 107. Middle East Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 108. Africa Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 109. Africa Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 110. Africa Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 111. Africa Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 112. North America Std Self Diagnostics, by Country USD Million (2016-2021)
  • Table 113. North America Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 114. North America Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 115. North America Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 116. North America Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 117. United States Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 118. United States Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 119. United States Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 120. United States Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 121. Canada Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 122. Canada Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 123. Canada Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 124. Canada Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 125. Mexico Std Self Diagnostics, by Type USD Million (2016-2021)
  • Table 126. Mexico Std Self Diagnostics, by Application USD Million (2016-2021)
  • Table 127. Mexico Std Self Diagnostics, by Usability USD Million (2016-2021)
  • Table 128. Mexico Std Self Diagnostics, by Testing USD Million (2016-2021)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Std Self Diagnostics: by Type(USD Million)
  • Table 141. Std Self Diagnostics Testing Kit , by Region USD Million (2022-2027)
  • Table 142. Std Self Diagnostics Testing Device , by Region USD Million (2022-2027)
  • Table 143. Std Self Diagnostics Testing Strip/chip , by Region USD Million (2022-2027)
  • Table 144. Std Self Diagnostics: by Application(USD Million)
  • Table 145. Std Self Diagnostics Hospitals , by Region USD Million (2022-2027)
  • Table 146. Std Self Diagnostics Homecare , by Region USD Million (2022-2027)
  • Table 147. Std Self Diagnostics Diagnostic Centres , by Region USD Million (2022-2027)
  • Table 148. Std Self Diagnostics Others , by Region USD Million (2022-2027)
  • Table 149. Std Self Diagnostics: by Usability(USD Million)
  • Table 150. Std Self Diagnostics Reusable , by Region USD Million (2022-2027)
  • Table 151. Std Self Diagnostics Disposable , by Region USD Million (2022-2027)
  • Table 152. Std Self Diagnostics: by Testing(USD Million)
  • Table 153. Std Self Diagnostics Chlamydia Testing , by Region USD Million (2022-2027)
  • Table 154. Std Self Diagnostics Gonorrhoea Testing , by Region USD Million (2022-2027)
  • Table 155. Std Self Diagnostics Hepatitis C Testing , by Region USD Million (2022-2027)
  • Table 156. Std Self Diagnostics HIV Testing , by Region USD Million (2022-2027)
  • Table 157. Std Self Diagnostics Syphilis Testing , by Region USD Million (2022-2027)
  • Table 158. Std Self Diagnostics Trichomonas’s Testing , by Region USD Million (2022-2027)
  • Table 159. South America Std Self Diagnostics, by Country USD Million (2022-2027)
  • Table 160. South America Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 161. South America Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 162. South America Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 163. South America Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 164. Brazil Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 165. Brazil Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 166. Brazil Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 167. Brazil Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 168. Argentina Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 169. Argentina Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 170. Argentina Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 171. Argentina Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 172. Rest of South America Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 173. Rest of South America Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 174. Rest of South America Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 175. Rest of South America Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 176. Asia Pacific Std Self Diagnostics, by Country USD Million (2022-2027)
  • Table 177. Asia Pacific Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 178. Asia Pacific Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 179. Asia Pacific Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 180. Asia Pacific Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 181. China Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 182. China Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 183. China Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 184. China Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 185. Japan Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 186. Japan Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 187. Japan Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 188. Japan Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 189. India Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 190. India Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 191. India Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 192. India Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 193. South Korea Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 194. South Korea Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 195. South Korea Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 196. South Korea Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 197. Taiwan Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 198. Taiwan Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 199. Taiwan Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 200. Taiwan Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 201. Australia Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 202. Australia Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 203. Australia Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 204. Australia Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 205. Rest of Asia-Pacific Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 206. Rest of Asia-Pacific Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 207. Rest of Asia-Pacific Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 208. Rest of Asia-Pacific Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 209. Europe Std Self Diagnostics, by Country USD Million (2022-2027)
  • Table 210. Europe Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 211. Europe Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 212. Europe Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 213. Europe Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 214. Germany Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 215. Germany Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 216. Germany Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 217. Germany Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 218. France Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 219. France Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 220. France Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 221. France Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 222. Italy Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 223. Italy Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 224. Italy Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 225. Italy Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 226. United Kingdom Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 227. United Kingdom Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 228. United Kingdom Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 229. United Kingdom Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 230. Netherlands Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 231. Netherlands Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 232. Netherlands Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 233. Netherlands Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 234. Rest of Europe Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 235. Rest of Europe Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 236. Rest of Europe Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 237. Rest of Europe Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 238. MEA Std Self Diagnostics, by Country USD Million (2022-2027)
  • Table 239. MEA Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 240. MEA Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 241. MEA Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 242. MEA Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 243. Middle East Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 244. Middle East Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 245. Middle East Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 246. Middle East Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 247. Africa Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 248. Africa Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 249. Africa Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 250. Africa Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 251. North America Std Self Diagnostics, by Country USD Million (2022-2027)
  • Table 252. North America Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 253. North America Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 254. North America Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 255. North America Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 256. United States Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 257. United States Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 258. United States Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 259. United States Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 260. Canada Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 261. Canada Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 262. Canada Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 263. Canada Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 264. Mexico Std Self Diagnostics, by Type USD Million (2022-2027)
  • Table 265. Mexico Std Self Diagnostics, by Application USD Million (2022-2027)
  • Table 266. Mexico Std Self Diagnostics, by Usability USD Million (2022-2027)
  • Table 267. Mexico Std Self Diagnostics, by Testing USD Million (2022-2027)
  • Table 268. Research Programs/Design for This Report
  • Table 269. Key Data Information from Secondary Sources
  • Table 270. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Std Self Diagnostics: by Type USD Million (2016-2021)
  • Figure 5. Global Std Self Diagnostics: by Application USD Million (2016-2021)
  • Figure 6. Global Std Self Diagnostics: by Usability USD Million (2016-2021)
  • Figure 7. Global Std Self Diagnostics: by Testing USD Million (2016-2021)
  • Figure 8. South America Std Self Diagnostics Share (%), by Country
  • Figure 9. Asia Pacific Std Self Diagnostics Share (%), by Country
  • Figure 10. Europe Std Self Diagnostics Share (%), by Country
  • Figure 11. MEA Std Self Diagnostics Share (%), by Country
  • Figure 12. North America Std Self Diagnostics Share (%), by Country
  • Figure 13. Global Std Self Diagnostics share by Players 2021 (%)
  • Figure 14. Global Std Self Diagnostics share by Players (Top 3) 2021(%)
  • Figure 15. Global Std Self Diagnostics share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Danaher Corporation (United States) Revenue: by Geography 2021
  • Figure 19. Affymetrix (United States) Revenue, Net Income and Gross profit
  • Figure 20. Affymetrix (United States) Revenue: by Geography 2021
  • Figure 21. BioMerieux (France) Revenue, Net Income and Gross profit
  • Figure 22. BioMerieux (France) Revenue: by Geography 2021
  • Figure 23. Cepheid Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Cepheid Inc. (United States) Revenue: by Geography 2021
  • Figure 25. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 26. Bio-Rad Laboratories (United States) Revenue: by Geography 2021
  • Figure 27. Alere Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Alere Inc. (United States) Revenue: by Geography 2021
  • Figure 29. DiaSorin (Italy) Revenue, Net Income and Gross profit
  • Figure 30. DiaSorin (Italy) Revenue: by Geography 2021
  • Figure 31. Orasure (United States) Revenue, Net Income and Gross profit
  • Figure 32. Orasure (United States) Revenue: by Geography 2021
  • Figure 33. F. Hoffmann-La Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. F. Hoffmann-La Roche (Switzerland) Revenue: by Geography 2021
  • Figure 35. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 36. Abbott Laboratories (United States) Revenue: by Geography 2021
  • Figure 37. Becton Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 38. Becton Dickinson and Company (United States) Revenue: by Geography 2021
  • Figure 39. Global Std Self Diagnostics: by Type USD Million (2022-2027)
  • Figure 40. Global Std Self Diagnostics: by Application USD Million (2022-2027)
  • Figure 41. Global Std Self Diagnostics: by Usability USD Million (2022-2027)
  • Figure 42. Global Std Self Diagnostics: by Testing USD Million (2022-2027)
  • Figure 43. South America Std Self Diagnostics Share (%), by Country
  • Figure 44. Asia Pacific Std Self Diagnostics Share (%), by Country
  • Figure 45. Europe Std Self Diagnostics Share (%), by Country
  • Figure 46. MEA Std Self Diagnostics Share (%), by Country
  • Figure 47. North America Std Self Diagnostics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Danaher Corporation (United States)
  • Affymetrix (United States)
  • BioMerieux (France)
  • Cepheid Inc. (United States)
  • Bio-Rad Laboratories (United States)
  • Alere Inc. (United States)
  • DiaSorin (Italy)
  • Orasure (United States)
  • F. Hoffmann-La Roche (Switzerland)
  • Abbott Laboratories (United States)
  • Becton Dickinson and Company (United States)
Select User Access Type

Key Highlights of Report


Jul 2022 166 Pages 53 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Std Self Diagnostics Market Quantitative research analysis
Global Std Self Diagnostics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Danaher Corporation (United States), Affymetrix (United States), BioMerieux (France), Cepheid Inc. (United States), Bio-Rad Laboratories (United States), Alere Inc. (United States), DiaSorin (Italy), Orasure (United States), F. Hoffmann-La Roche (Switzerland), Abbott Laboratories (United States) and Becton Dickinson and Company (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increase In Recommendation from Doctor" is seen as one of major influencing trends for Std Self Diagnostics Market during projected period 2021-2027.
The Std Self Diagnostics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Std Self Diagnostics Market Report?

Have a Query? Click Here

Other Related Reports

Microbiological Testing Service Comprehensive Study by Application (Clinical Disease Diagnostics, Food & Beverage testing, Pharmaceutical & Biological Drug Testing, Environmental Testing, Cosmetics a...
$ 3750
Personal Genome Services Comprehensive Study by Application (Drug Discovery and Development, Diagnostics, Agriculture and Animal Research, Other), Technology (Sequencing, PCR, Nucleic Acid Extraction...
$ 3750
Urea Breath Test Systems Comprehensive Study by Type (Urea Breath Test Kits, Urea Breath Test Analyzer), Application (Hospitals, Specialized Clinics, Laboratories, Others), Tests (Invasive, Non-invas...
$ 3500
Prescription Pharmacy Bags Comprehensive Study by Type (Flat bag, Square-bottomed Bag, Gusseted Bag), Application (Pharmacies and Dispensaries, Hospitals, Dental/Eye-care/Dermatology clinics, Veterin...
$ 3450
Rapid Adenovirus Testing Comprehensive Study by Application (Hospitals, Clinics, Others), Assay (Lateral Flow Immunochromatographic Assay, Immunogold Assay, PCR-Enzyme Hybridization Assay), Diagnosis...
$ 3650
Iron Deficiency Anemia Treatment Comprehensive Study by Application (Inflammatory Bowel Disease, Chronic Kidney Disease, Dialysis, Chronic Heart Failure, Women’s Health, Celiac Disease, Others {Cance...
$ 3750